Abstract
The identification of early diagnostic markers of tumour pathology of the thyroid gland plays an important role. Our study aimed to determine changes in NO metabolism in various benign and malignant thyroid pathologies. The content of NO in the blood serum of healthy individuals and patients (with thyrotoxicosis, benign thyroid tumour and thyroid cancer) was studied. In patients with thyrotoxicosis, the content of NO in the blood serum increases statistically significantly by 33%, and in benign tumour pathology - by 22% compared with control indicators; In patients with thyroid cancer, the content of NO in the blood serum did not statistically significantly different from the level of control parameters.The present study has the potential to present elevated levels of NO in the blood of patients, compared with controls, as a marker to rule out thyroid cancer. Further clinical studies are needed to obtain comprehensive results and elucidate the relationship between NO metabolism and thyroid pathologies.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
